# Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients

> **NCT04269863** · NA · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 150 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT04269863
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269863, "Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04269863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*